Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Gains from Sales and Divestitures: 2009-2024

  • Innoviva's Gains from Sales and Divestitures fell 15.14% to $241,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $241,000, marking a year-over-year decrease of 15.14%. This contributed to the annual value of $241,000 for FY2024, which is 15.14% down from last year.
  • Innoviva's Gains from Sales and Divestitures amounted to $241,000 in Q4 2024, which was down 15.14% from $284,000 recorded in Q4 2023.
  • Innoviva's Gains from Sales and Divestitures' 5-year high stood at $284,000 during Q4 2023, with a 5-year trough of $86 in Q4 2021.
  • Its 3-year average for Gains from Sales and Divestitures is $252,667, with a median of $241,000 in 2024.
  • As far as peak fluctuations go, Innoviva's Gains from Sales and Divestitures tumbled by 99.91% in 2021, and later surged by 270,830.23% in 2022.
  • Innoviva's Gains from Sales and Divestitures (Quarterly) stood at $94,000 in 2020, then tumbled by 99.91% to $86 in 2021, then soared by 270,830.23% to $233,000 in 2022, then grew by 21.89% to $284,000 in 2023, then declined by 15.14% to $241,000 in 2024.
  • Its last three reported values are $241,000 in Q4 2024, $284,000 for Q4 2023, and $233,000 during Q4 2022.